Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
ERJ Open Research|August 5, 2021
Early risk prediction in idiopathic <i>versus</i> connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessmentClara Hjalmarsson, Barbro Kjellström, Kjell Jansson, et al.
Plos One|June 19, 2009
The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypesTimothy R D J Radstake, Lenny van Bon, Jasper Broen, et al.
Arthritis Research & Therapy|September 4, 2023
Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory studyViggo Hamberg, Azita Sohrabian, Elizabeth R Volkmann, et al.
Arthritis Research & Therapy|July 31, 2021
An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimodRoger Hesselstrand, Jörg H W Distler, Gabriela Riemekasten, et al.
Clinical and Experimental Rheumatology|September 6, 2018
Determinants of health-related quality of life in a multinational systemic sclerosis inception cohortKathleen Morrisroe, Marie Hudson, Murray Baron, et al.
Plos One|July 22, 2016
Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren's Syndrome and Systemic SclerosisAnders A Bengtsson, Johan Trygg, Dirk M Wuttge, et al.
The Journal of Rheumatology|December 17, 2010
The functional polymorphism 844 A>G in FcαRI (CD89) does not contribute to systemic sclerosis or rheumatoid arthritis susceptibilityJasper C A Broen, Marieke J H Coenen, Blanca Rueda, et al.
BMJ Open|March 19, 2021
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocolJulia Spierings, Anna van Rhenen, Paco Mw Welsing, et al.
Pageof 3